Fresenius Group is a global healthcare company headquartered in Bad Homburg vor der Höhe, Germany, with a history spanning more than 100 years. The company provides system-critical products and services for therapies used in the care of critically and chronically ill patients. It employs around 176,000 people (excluding Fresenius Medical Care) and reported annual revenue of €21.5 billion in fiscal year 2024.
The group's operations are structured across several key business segments. Through its operating company Fresenius Kabi, it supplies products for critically and chronically ill patients. Fresenius Helios operates as Europe's leading private hospital operator. Additionally, through its investment company Fresenius Medical Care, the group is the world's leading provider of dialysis products and services, serving approximately 4.5 million patients worldwide through its dialysis services alone.
For legal professionals, the scope of Fresenius's operations spans multiple highly regulated industry verticals, including Pharmaceuticals, Medical Devices, Hospital Operations, and Dialysis Services. Its international footprint covers Europe, the Americas, and other global markets. Under the #FutureFresenius program, the company is organized around three therapy platforms: (Bio)Pharma including clinical nutrition, MedTech, and Care Provision, positioning itself for growth in an evolving healthcare landscape.
